Stratum expands portfolio with BLIS oral probiotics
Stratum Nutrition has added the oral probiotics BLIS K12 and BLIS M18 to its specialty product portfolio.
Archives for February 29, 2012
CRN welcomes FDA ‘wake-up’ call for GMP compliance
Many dietary supplement companies are not fully compliant with GMP regulations, putting them at risk of warning letters and more, but resources are available to help companies prepare for an FDA inspection, says the Council for Responsible Nutrition (CRN).
Leucine supplements may combat muscle loss in older people
The amino acid leucine may help older people synthesize muscle in response to lower protein meals, suggests a new study.
Volac launches consumer brand to push whey protein beyond macho male niche
European whey protein manufacturer Volac has launched its first consumer branded products to drive mainstream awareness of the benefits of whey protein beyond a macho male niche, and protect the market from outlandish health claims and poor quality products.
Short-term vitamin D + counseling may slash falls in malnourished seniors
Three months of supplementation with vitamin D, combined with calcium, more protein in the diet, and some expert advice, may reduce the number of falls in malnourished seniors, says a new study.
DSM readies €2bn+ acquisitions war chest as 2011 profit jumps 15%
Nutrition and polymers were the stand-out divisions for Royal DSM in 2011, a year that saw operating profits rise 15% from €752m to €866m, as the newly life science-oriented ingredients giant singled out Martek buy-out success and committed to ongoing...
Continuous monitoring needed for aflatoxins in chocolate – study
Researchers in Brazil have found high levels of the potentially lethal contaminant aflatoxin in chocolate and say constant monitoring is required.
ADM exit does not mean there is no demand for canola protein, insists Burcon
Canadian plant protein specialist Burcon NutraScience says it remains confident of finding a new partner to commercialize its canola proteins after it emerged that ADM will not now be taking the proteins to market – after eight years of talks.